Hydroxycarbamide - Polycythaemia, Thrombocythaemia and Myelofibrosis
You are here : Home > Formulary Search > Hydroxycarbamide - Polycythaemia, Thrombocythaemia and Myelofibrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
PAD Profile
ChemicalSubstance :
Hydroxycarbamide
Indication :
Polycythaemia, Thrombocythaemia and Myelofibrosis
Group Name :
Keywords :
Brand Names Include :
Hydrea
Important Information :
Initiation and 3 months of treatment to be provided by specilaist team before any requests for primary care prescribing.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Hydroxycarbamide is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Polycythaemia, Thrombocythaemia and Myelofibrosis.
- No records returned.
Committee Recommendations (1)
The PCN reviewed and agreed the updated Blue information sheet below which will be taken through internal governance processes a the provider trusts for agreement